Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gastroenterology

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2007.08.071PMID 17983806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.

  2007cited by this paper
• Liver Disease in Cystic Fibrosis

  2006cited by this paper
• Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

  2006cited by this paper
• Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis

  2006cited by this paper
• Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis

  2006cited by this paper
• Pathophysiology of cholangiopathies.

  2005cited by this paper
• Deoxycholic acid activates protein kinase C and phospholipase C via increased Ca2+ entry at plasma membrane.

  2005cited by this paper
• PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors

  2005cited by this paper
• Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.

  2005cited by this paper
• Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism.

  2005cited by this paper
• Isolation and characterization of subcellular protein fractions from mouse heart.

  2005cited by this paper
• Purinergic regulation of cholangiocyte secretion: identification of a novel role for P2X receptors.

  2005cited by this paper
• α‐1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca2+‐ and PKC‐dependent stimulation of cAMP

  2004cited by this paper
• Impaired Regulatory Volume Decrease in Freshly Isolated Cholangiocytes from Cystic Fibrosis Mice

  2004cited by this paper
• P2Y‐mediated Ca2+ response is spatiotemporally graded and synchronized in sensory neurons: a two‐photon photolysis study

  2004cited by this paper
• The cholangiopathies: disorders of biliary epithelia.

  2004cited by this paper
• Vesicular exocytosis contributes to volume-sensitive ATP release in biliary cells.

  2004cited by this paper
• Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.

  2004cited by this paper
• Agonist-induced Coordinated Trafficking of Functionally Related Transport Proteins for Water and Ions in Cholangiocytes*

  2003cited by this paper
• Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium.

  2003cited by this paper
• Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator

  2003cited by this paper
• Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes.

  2003cited by this paper
• Correction of CFTR malfunction and stimulation of Ca2+‐activated Cl− channels restore HCO  3− secretion in cystic fibrosis bile ductular cells

  2002cited by this paper
• Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

  2002cited by this paper
• Regulation of Ca2+ signaling in rat bile duct epithelia by inositol 1,4,5‐trisphosphate receptor isoforms

  2002cited by this paper
• Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha

  2002cited by this paper
• Proinflammatory cytokines inhibit secretion in rat bile duct epithelium.

  2001cited by this paper
• Purinergic-independent Calcium Signaling Mediates Recovery from Hepatocellular Swelling

  2001cited by this paper
• Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway*

  2001cited by this paper
• Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia.

  2001cited by this paper
• Stimulation of ATP secretion in the liver by therapeutic bile acids.

  2001cited by this paper
• Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver.

  2001cited by this paper
• Ca2+‐activated Cl− channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion

  2000cited by this paper
• Pathophysiology of the intrahepatic biliary epithelium

  2000cited by this paper
• ABC transporter-facilitated ATP conductive transport.

  1999cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines

  1998cited by this paper
• Subcellular analysis of Ca2+ homeostasis in primary cultures of skeletal muscle myotubes.

  1997cited by this paper
• Regulation of biliary secretion through apical purinergic receptors in cultured rat cholangiocytes.

  1997cited by this paper
• Regulation of biliary secretion through apical purinergic receptors in cultured rat cholangiocytes.

  1997cited by this paper
• Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides.

  1996cited by this paper
• Ursodeoxycholate increases cytosolic calcium concentration and activates Cl- currents in a biliary cell line.

  1995cited by this paper
• A mouse model for the delta F508 allele of cystic fibrosis.

  1995cited by this paper
• Isolation of small polarized bile duct units.

  1995cited by this paper
• Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium‐like cell line

  1994cited by this paper
• Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.

  1993cited by this paper
• Protein kinase C activates chloride conductance in C127 cells stably expressing the cystic fibrosis gene.

  1993cited by this paper
• An Animal Model for Cystic Fibrosis Made by Gene Targeting

  1992cited by this paper
• Cell-permeable fluorescent indicator for cytosolic chloride.

  1991cited by this paper

• Plasma membrane Bile acid TGR5 receptor specific stimulation induces Ca2+ mobilisation, ATP secretion and P2Y receptors activation in cholangiocytes.

  2025cites this paper
• A novel model to study mechanisms of cholestasis in human cholangiocytes reveals a role for the SIPR2 pathway

  2024cites this paper
• Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.

  2024cites this paper
• Finite volume simulation of calcium distribution in a cholangiocyte cell

  2023cites this paper
• Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice

  2021cites this paper
• L iver manifestation associated with COVID-19 (Literature review)

  2021cites this paper
• Fundamentals of Bicarbonate Secretion in Epithelia

  2020cites this paper
• Ca2+Signaling in the Liver

  2020cites this paper
• Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies

  2020cites this paper
• Pathophysiological mechanisms of liver injury in COVID‐19

  2020cites this paper
• Animal models for cystic fibrosis liver disease (CFLD).

  2019cites this paper
• Type 3 inositol 1,4,5-trisphosphate receptor: A calcium channel for all seasons.

  2019influential citation
• The mechanosensor Transient Receptor Potential Vanilloid Member 4 (TRPV4) regulates mouse cholangiocyte secretion and bile formation.

  2019cites this paper
• UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.

  2019cites this paper
• Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota

  2019cites this paper
• Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies

  2019cites this paper
• Calcium Signaling in Cholangiocytes: Methods, Mechanisms, and Effects

  2018influential citation
• ChapTEr 5 URSODEOXYCHOLIC ACID MODULATES BILE FLOW AND BILE SALT POOL INDEPENDENTLY OF THE CYSTIC FIBROSIS TRANSMEMBRANE REGULATORY GENE IN MICE

  2018cites this paper
• Calcium Signaling in Liver Injury and Regeneration

  2018influential citation
• Controlled Release of Ursodeoxycholic Acid from Pullulan Acetate Nanoparticles to Modulate Glutamate-Induced Excitotoxicity in PC-12 Cells

  2018cites this paper
• Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl− channels

  2018influential citation
• Role of Bile Acids and the Biliary HCO3- Umbrella in the Pathogenesis of Primary Biliary Cholangitis.

  2018cites this paper
• Effects of Endotoxin on Type 3 Inositol 1,4,5‐Trisphosphate Receptor in Human Cholangiocytes

  2018cites this paper
• Cystic fibrosis transmembrane conductance regulator: Actin(g) as a master regulator of cholangiocyte function

  2018cites this paper
• Regulation of bile secretion by calcium signaling in health and disease.

  2018cites this paper
• Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases

  2017cites this paper
• Animal models of biliary injury and altered bile acid metabolism.

  2017cites this paper
• CFTR : Actin ( g ) as a master regulator of cholangiocyte function

  2017cites this paper
• Signaling Pathways in Liver Diseases - ReadingSample

  2017cites this paper
• Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy

  2017cites this paper
• The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity

  2016cites this paper
• Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement

  2016cites this paper
• Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson’s Disease: Modulation of Mitochondrial Perturbations

  2016cites this paper
• Regulation of mechanosensitive biliary epithelial transport by the epithelial Na+ channel

  2016cites this paper
• Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis.

  2016cites this paper
• CDCA Activation of CFTR-Dependent Cl- Secretion Requires a Complex Network of Signaling Cascades

  2016cites this paper
• Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells

  2015cites this paper
• Huqi San-Evoked Rat Colonic Anion Secretion through Increasing CFTR Expression

  2015cites this paper
• Liver alkaline phosphatase: A missing link between choleresis and biliary inflammation

  2015cites this paper
• Ezrin finds its groove in cholangiocytes

  2015cites this paper
• Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12.

  2015cites this paper
• Calcium signaling and secretion in cholangiocytes.

  2015cites this paper
• Bile acids regulate colonic epithelial barrier function: implications for pathogenesis and therapy of inflammatory bowel disease

  2015cites this paper
• The biliary tree in health and immune-mediated disease

  2015cites this paper
• Bile secretion and cholestasis

  2015cites this paper
• Stimulation of nuclear receptor peroxisome proliferator–activated receptor‐γ limits NF‐κB‐dependent inflammation in mouse cystic fibrosis biliary epithelium

  2015cites this paper
• Adenylyl cyclases in the digestive system.

  2014cites this paper
• Cystic fibrosis liver disease and the enterohepatic circulation of bile acids

  2014influential citation
• Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells

  2014cites this paper
• The Actions of Ursodeoxycholic Acid and its derivatives on Colonic Epithelial Transport and Barrier Function

  2014cites this paper
• Liver disease in cystic fibrosis

  2014cites this paper
• URSODEOXYCHOLATE MODULATES BILE FLOW AND BILE SALT POOL INDEPENDENTLY FROM CFTR IN MICE

  2014influential citation
• Calcium signaling and the secretory activity of bile duct epithelia.

  2014cites this paper
• Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells.

  2014cites this paper
• P1253 ACTIVATION OF PPAR-γ SIGNALING AS A NOVEL TARGET TO LIMIT NF-κB-DEPENDENT INFLAMMATION IN CYSTIC FIBROSIS BILIARY EPITHELIUM

  2014cites this paper
• Anatomy and Physiology of the Biliary Epithelium

  2014cites this paper
• Physiology of cholangiocytes.

  2013cites this paper
• Purinergic signalling in the gastrointestinal tract and related organs in health and disease

  2013cites this paper
• Role of AE2 for pHi regulation in biliary epithelial cells

  2013cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid

  2013cites this paper
• Calcium signaling in the liver.

  2013cites this paper
• Placenta-Derived Stem Cells as a Source for Treatment of Lung and Liver Disease in Cystic Fibrosis

  2013cites this paper
• A cholecystohepatic shunt pathway: does the gallbladder protect the liver?

  2012cites this paper
• Urosdeoxycholic acid in primary sclerosing cholangitis: a meta-analysis and systematic review.

  2012cites this paper
• Chapter 56 – Physiology of Cholangiocytes

  2012cites this paper
• Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

  2012cites this paper
• Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.

  2012cites this paper
• A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes

  2012cites this paper
• Molecular Targets for the Treatment of Fibrosing Cholangiopathies

  2012cites this paper
• Physiology of Cholangiocytes

  2012influential citation
• Coexpression of ecto-5′-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver

  2012cites this paper
• Role of epithelial to mesenchymal transition in genetic cholangiopathies related to fibrocystin deficiency

  2011cites this paper
• Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.

  2011cites this paper
• Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.

  2011cites this paper
• Purinergic signalling in epithelial ion transport: regulation of secretion and absorption

  2011cites this paper
• Co-expression of ecto-5 ’-nucleotidase / CD 73 with 1 specific NTPDases differentially regulates 2 adenosine formation in the rat liver 3 4

  2011cites this paper
• Biliary Epithelial Cells

  2011cites this paper
• Cystic Fibrosis and the gastro-intestinal tract

  2011cites this paper
• adenosine formation in the rat liver

  2011cites this paper
• The effect of cystic fibrosis transmembrane conductance regulator on the function of acid/base transporters of human pancreatic duct cells

  2011cites this paper
• Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat

  2011cites this paper
• Role of the Anion Exchanger 2 in the Pathogenesis and Treatment of Primary Biliary Cirrhosis

  2011cites this paper
• The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies

  2010cites this paper
• Approach to the Patient with Cholestasis and Jaundice

  2010cites this paper
• Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.

  2010cites this paper
• Pathogenesis of cholestatic liver disease and therapeutic approaches.

  2010cites this paper
• Biliary secretion of S‐nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat

  2010influential citation
• Identification and Functional Characterization of TMEM16A, a Ca2+-activated Cl− Channel Activated by Extracellular Nucleotides, in Biliary Epithelium*

  2010cites this paper
• Cholangiocyte Biology as Relevant to Cystic Liver Diseases

  2010cites this paper
• Cystic fibrosis-associated liver disease.

  2010cites this paper
• Anatomy and Physiology of the Biliary Epithelium

  2010cites this paper
• Signaling Pathways in Biliary Epithelial Cells

  2010cites this paper
• Adenosine triphosphate release and purinergic (P2) receptor–mediated secretion in small and large mouse cholangiocytes

  2010cites this paper
• Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid–induced cholestasis in rat liver

  2010cites this paper
• Bile salts and cholestasis.

  2010cites this paper
• Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.

  2010cites this paper
• Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice

  2010cites this paper
• Primary biliary cirrhosis: a 2010 update.

  2010cites this paper
• CFTR Expression But Not Cl− Transport Is Involved in the Stimulatory Effect of Bile Acids on Apical Cl−/HCO3− Exchange Activity in Human Pancreatic Duct Cells

  2009influential citation